Antiviral Drug Stockpiling in Preparation for an Influenza Pandemic

Published on:
July 7, 2008

SIFMA provides comments to the U.S. Department of Health and Human Services (HHS) on Draft Guidance to Assist in the Preparation for an Influenza Pandemic, particularly the Proposed Considerations for Antiviral Drug Stockpiling by Employers in Preparation for an Influenza Pandemic.  SIFMA agrees that as a part of the country’s critical infrastructure, securities firms must plan for a pandemic as part of overall business continuity planning.  SIFMA urges HHS and the Center for Disease Control (CDC) to emphasize that the decision to stockpile antiviral medications should be at the sole discretion of the employer, but that special attention should be paid to the liability behind how firms disperse prescription drugs.

Details

Download

More Content

  • Letters
    Nov 09, 2026

    Political Contributions by Certain Investment Advisers (SIFMA AMG)

    SIFMA AMG supports the SEC’s proposal to rescind the investment adviser pay-to-play rule, citing compliance burdens, costs and restrictions on political speech.
  • Letters
    Nov 09, 2026

    Political Contributions by Certain Investment Advisers

    SIFMA comments on the SEC’s proposal to rescind the political contributions rule for investment advisers, citing compliance burdens and existing safeguards.
  • Amicus Briefs
    Nov 06, 2026

    Blockchain Assoc. and Crypto Council for Innovation v. IL

Get the latest trends, stats, and research on financial markets and securities.